Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein
暂无分享,去创建一个
L. Senggunprai | V. Kukongviriyapan | A. Prawan | Piman Pocasap | Putthaporn Kaewmeesri | S. Kongpetch
[1] R. Rossi,et al. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. , 2022, Annals of hepatology.
[2] Yen-Cheng Chen,et al. Targeting Src-Hic-5 Signal Cascade for Preventing Migration of Cholangiocarcinoma Cell HuCCT1 , 2022, Biomedicines.
[3] Jing Yang,et al. Tumor metastasis: Mechanistic insights and therapeutic interventions , 2021, MedComm.
[4] A. Fiorentino,et al. Non-surgical treatment of hilar cholangiocarcinoma , 2021, World journal of gastrointestinal oncology.
[5] H. Cárdenas,et al. Hydroethanolic Extracts of the Aristotelia Chilensis (Maqui) Berry Reduces Cellular Viability and Invasiveness in the Endometrial Cancer Cell Line Ishikawa , 2021, Integrative cancer therapies.
[6] L. Senggunprai,et al. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells. , 2020, The American journal of Chinese medicine.
[7] G. Barillari. The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process , 2020, International journal of molecular sciences.
[8] S. Uddin,et al. Inducing Angiogenesis, a Key Step in Cancer Vascularization, and Treatment Approaches , 2020, Cancers.
[9] D. Muntham,et al. Clinical Prognostic Factors and Treatment Outcomes for the Survival of Patients with Cholangiocarcinoma in the Eastern Region of Thailand , 2019, Asian Pacific Journal of Cancer Care.
[10] Y. Hsieh,et al. Thymoquinone inhibits metastasis of renal cell carcinoma cell 786-O-SI3 associating with downregulation of MMP-2 and u-PA and suppression of PI3K/Src signaling , 2019, International journal of medical sciences.
[11] S. Pereira,et al. Molecular Pathogenesis of Cholangiocarcinoma , 2019, BMC Cancer.
[12] Muhammad Maqsood Alam,et al. Potential phytochemicals in the fight against skin cancer: Current landscape and future perspectives. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[13] L. Senggunprai,et al. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells , 2018, Integrative cancer therapies.
[14] H. Jang,et al. Cucurbitacin B Induces Hypoglycemic Effect in Diabetic Mice by Regulation of AMP-Activated Protein Kinase Alpha and Glucagon-Like Peptide-1 via Bitter Taste Receptor Signaling , 2018, Front. Pharmacol..
[15] N. Akhtar,et al. Plant derived anticancer agents: A green approach towards skin cancers. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[16] J. Iqbal,et al. Potential phytocompounds for developing breast cancer therapeutics: Nature’s healing touch , 2018, European journal of pharmacology.
[17] N. Khuntikeo,et al. Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia , 2018, Front. Med..
[18] S. Kaul,et al. Cucurbitacin B and cancer intervention: Chemistry, biology and mechanisms (Review). , 2017, International journal of oncology.
[19] L. Fabris,et al. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. , 2017, Gene expression.
[20] James T. Webber,et al. Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma. , 2016, Cancer discovery.
[21] Sun Young Park,et al. Cucurbitacin B inhibits immunomodulatory function and the inflammatory response in macrophages , 2015, Immunopharmacology and immunotoxicology.
[22] Arthur J Olson,et al. Small-molecule library screening by docking with PyRx. , 2015, Methods in molecular biology.
[23] S. Boxer,et al. A conserved water-mediated hydrogen bond network defines bosutinib’s kinase selectivity , 2013, Nature chemical biology.
[24] Abdullah A Alghasham,et al. Cucurbitacins - a promising target for cancer therapy. , 2013, International journal of health sciences.
[25] Pei-Hsuan Chen,et al. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways. , 2011, The Journal of nutritional biochemistry.
[26] R. Agarwal,et al. Role of E-cadherin in Antimigratory and Antiinvasive Efficacy of Silibinin in Prostate Cancer Cells , 2011, Cancer Prevention Research.
[27] E. Grande,et al. The dual kinase complex FAK-Src as a promising therapeutic target in cancer , 2010, OncoTargets and therapy.
[28] Jie Zhang,et al. SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines. , 2007, The American journal of pathology.
[29] J. Guan,et al. Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1. , 2005, World journal of gastroenterology.
[30] T. Boggon,et al. Structure and regulation of Src family kinases , 2004, Oncogene.
[31] G. Gallick,et al. Src family kinases in tumor progression and metastasis , 2003, Cancer and Metastasis Reviews.
[32] Heike Allgayer,et al. Activation of Src kinase in primary colorectal carcinoma , 2002, Cancer.
[33] T. Yeatman,et al. Role of Src expression and activation in human cancer , 2000, Oncogene.
[34] G. Staal,et al. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. , 1992, Cancer research.